| 000 | 04013naa a22005057i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-060 | ||
| 003 | local | ||
| 005 | 20261005174906.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2018 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.3748/wjg.v24.i35.4000 _2doi |
|
| 035 | _a(local)EuropePMC:PMC6148422 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aArchana Rastogi _eauthor. |
|
| 245 | 1 | 0 |
_aChanging role of histopathology in the diagnosis and management of hepatocellular carcinoma. / _cArchana Rastogi. |
| 264 | 1 |
_a[Place of publication not identified] : _bBaishideng Publishing Group Inc, _c2018. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aHepatocellular carcinoma (HCC) is one of the most common and fatal cancer in the world. HCC frequently presents with advanced disease, has a high recurrence rate and limited treatment options, which leads to very poor prognosis. This warrants urgent improvement in the diagnosis and treatment. Liver biopsy plays very important role in the diagnosis and prognosis of HCC, but with technical advancements and progression in the field of imaging, clinical guidelines have restricted the role of biopsy to very limited situations. Biopsy also has its own problems of needle tract seeding of tumor, small risk of complications, technical and sampling errors along with interpretative errors. Despite this, tissue analysis is often required because imaging is not always specific, limited expertise and lack of advanced imaging in many centers and limitations of imaging in the diagnosis of small, mixed and other variant forms of HCC. In addition, biopsy confirmation is often required for clinical trials of new drugs and targeted therapies. Tissue biomarkers along with certain morphological features, phenotypes and immune-phenotypes that serve as important prognostic and outcome predictors and as decisive factors for therapy decisions, add to the continuing role of histopathology. Advancements in cancer biology and development of molecular classification of HCC with clinic pathological correlation, lead to discovery of HCC phenotypic surrogates of prognostic and therapeutically significant molecular signatures. Thus tissue characteristics and morphology based correlates of molecular subtypes provide invaluable information for management and prognosis. This review thus focuses on the importance of histopathology and resurgence of role of biopsy in the diagnosis, management and prognostication of HCC. | |
| 540 |
_aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms. _uhttp://creativecommons.org/licenses/by-nc/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aImmunohistochemistry | |
| 650 | 4 | _aHepatocellular carcinoma | |
| 650 | 4 | _aMolecular | |
| 650 | 4 | _aDiagnosis | |
| 650 | 4 | _aPrognosis | |
| 650 | 4 | _aBiomarker | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _ahistopathology | ||
| 655 | 4 | _aReview articles. | |
| 773 | 0 |
_tWorld journal of gastroenterology _gVol. 24, no. 35, (2018), pages/article 4000-4013 _x1007-9327 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC6148422 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC6148422 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1202 _d1202 |
||